BIA
ADMA icon

Bell Investment Advisors’s ADMA Biologics ADMA Stock Holding History

Bell Investment Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369 Hold
44
– – ﹤0.01% 1778
2026
Q1 		$397 Hold
44
– – ﹤0.01% 1816
2025
Q4 		$803 Sell
44
-41
-48% -$691 ﹤0.01% 1601
2025
Q3 		$1.25K Sell
85
-90
-51% -$1.54K ﹤0.01% 1503
2025
Q2 		$3.19K Buy
175
+27
+18% +$551 ﹤0.01% 1173
2025
Q1 		$2.94K Hold
148
– – ﹤0.01% 1152
2024
Q4 		$2.54K Sell
148
-6
-4% -$113 ﹤0.01% 1237
2024
Q3 		$3.08K Buy
+154
New +$2.4K ﹤0.01% 1173

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bell Investment Advisors's ADMA Position: Q2 2026 in Review

Bell Investment Advisors held its ADMA Biologics (ADMA) position steady in Q2 2026 at 44 shares worth $369. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

Bell Investment Advisors first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.19K in Q2 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Bell Investment Advisors held 44 shares of ADMA Biologics worth $369 as of Q2 2026.
  • Bell Investment Advisors left its ADMA Biologics share count unchanged in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1778 holding.
  • Bell Investment Advisors first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Bell Investment Advisors's ADMA Biologics position peaked at $3.19K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.